EDF Health

Selected tag(s): South Korea

Public pressure gets the job done: South Korea passes new chemicals law, K-REACH

Alissa Sasso is a Chemicals Policy Fellow.

Two years ago, accidental use of a chemical in humidifiers in South Korea tragically took the lives of 18 people and captured national headlines. Nearly a year later another fatal accident occurred at a chemical plant, this time injuring thousands of people in the surrounding area as well.

Meanwhile, the South Korean National Assembly was negotiating a new comprehensive chemicals bill that some observers saw as leaning in favor of the business interests at the table. The tragedies brought the public spotlight to the issue and changed the political dynamic and policy outcome.  With the public calling for greater control over toxic chemicals, legislators reinstated many of the health-protective requirements that had been dropped due to industry pressure (Chemical Watch, subscription required). And on April 30th, 2013, the Assembly passed the “Act on the Registration and Evaluation of Chemicals”, known as “Korea REACH” or simply “K-REACH” (Chemical Watch, subscription required).  Read More »

Posted in Health policy, International / Also tagged , | Comments are closed

Onwards and upwards: South Korea and Turkey advance their REACH-like policies

Alissa Sasso is a Chemicals Policy Fellow. Richard Denison, Ph.D., is a Senior Scientist.

This summer we saw a flurry of activity surrounding our own chemical safety legislation, the Toxic Substances Control Act (TSCA); international reform efforts have been just as busy. In this blog post, we’ll discuss recent developments in toxic chemicals management in South Korea and Turkey. As apparent in our recent post on new Chinese regulations, these developments are notable because of their alignment with the EU’s REACH legislation.  Read More »

Posted in Health policy, International / Also tagged , , | Comments are closed

Ripples of REACH: Chemicals policy changes in Japan, Turkey and South Korea

Allison Tracy is a Chemicals Policy Fellow. Richard Denison, Ph.D., is a Senior Scientist.

The November 31st deadline for the first batch of registrations under REACH (the European Union’s Regulation for Registration, Evaluation, Authorization and Restriction of Chemicals) may have passed, but life is far from dull on the international scene of chemicals policy.  As discussed in a previous post, chemicals policy enhancements are ramping up across the globe, many of them mirroring the innovations introduced under REACH.

In this post, we’ll discuss significant advances in Japan, Turkey and South Korea that drive home the message that the ripples from REACH are ever-widening.  Read More »

Posted in Health policy, International / Also tagged , , , , , , , , | Comments are closed

One solid step for REACH, one giant leap for chemicals policy

Allison Tracy is a Chemicals Policy Fellow. Richard Denison, Ph.D., is a Senior Scientist.

While efforts to improve U.S. chemical safety legislation have been at, shall we say, a stand-still for the past few months, our European counterparts have been buzzing with activity.  U.S. NGOs, industry, regulators and lawmakers should be paying really close attention to all that buzz as they deliberate the shape of U.S. chemicals policy in the new Congress.

The European Chemicals Agency (ECHA) is currently in the thick of processing registrations received by the first major deadline under REACH, the European Union’s chemicals regulation for the Registration, Evaluation, Authorization and Restriction of Chemicals.  November 30, 2010 was the first of three deadlines for registering existing chemicals (termed “phase-in substances” under REACH); it applied to the highest-volume and most hazardous chemicals on the market.  Some 4,700 new and existing chemicals have now been registered under REACH since it took effect in mid-2008, including about 3,500 existing chemicals subject to that first deadline based on high volume or toxicity.

In contrast to Las Vegas, what is happening in Europe is not staying in Europe.  That alone makes it worth paying attention to.  Read More »

Posted in Health policy / Also tagged , , , , , , | Read 1 Response